Editorial
Copyright ©The Author(s) 2016.
World J Clin Oncol. Apr 10, 2016; 7(2): 149-154
Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.149
Figure 2
Figure 2 Different sequential alternatives to be used in advanced pancreatic neuroendocrine tumor patients based on approved agents. The term “chemotherapy” may include streptozocin ± 5-fluorouracil or doxorubicin, or temozolomide ± capecitabine.